DURECT Corporation Presenting at the Needham & Company Fifth Annual Biotechnology and Medical Technology Conference

Download PDF:

CUPERTINO, Calif., June 12 /PRNewswire-FirstCall/ — DURECT Corporation
(Nasdaq: DRRX) announced today that it will present a corporate overview at
the Needham & Company, LLC’s Fifth Annual Biotechnology and Medical Technology
Conference on Wednesday, June 14th at 8:30 a.m. EST. The conference is taking
place at The New York Palace Hotel in New York City, New York.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

A live audio webcast of the presentation will be available by accessing
DURECT’s homepage at http://www.www.durect.com and clicking “Investor Relations.”

About DURECT Corporation

DURECT Corporation is an emerging specialty pharmaceutical company focused
on the development of pharmaceutical systems based on its proprietary drug
delivery platform technologies. The company is developing pharmaceutical
systems to deliver the right drug to the right place in the right amount at
the right time to treat chronic and episodic diseases and conditions.

SOURCE DURECT Corporation
06/12/2006
CONTACT: Schond L. Greenway, Vice President, Investor Relations and
Strategic Planning of DURECT Corporation, +1-408-777-1417
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, +1-888-776-6555 or +1-212-782-2840
Web site: http://www.www.durect.com/
(DRRX)

Scroll to Top